Photobiomodulation (PBM) therapy is a relatively new modality for the combined treatment of cancer. Pre-treatment of certain types of cancer cells with PBM potentiates the treatment efficacy of photodynamic therapy (PDT). The mechanism of action of this synergetic effect is not yet fully understood. In the present study, we focused on protein kinase Cd (PKCd) as a proapoptotic agent that is highly expressed in U87MG cells. The distribution of PKCd in the cytoplasm was changed and its concentration was increased by PBM using radiation at 808 nm (15 mW/cm(2), 120 s). This process was accompanied by the organelle specific phosphorylation of PKCd amino acids (serine/tyrosine). Enhanced phosphorylation of serine 645 in the catalytic domain of PKCd was found in the cytoplasm, whereas the phosphorylation of tyrosine 311 was mainly localized in the mitochondria. Despite a local increase in the level of oxidative stress, only a small amount of cytochrome c was released from the mitochondria to cytosol. Although a partial inhibition of mitochondrial metabolic activity was induced in PBM-exposed cells, apoptosis was not observed. We hypothesized that PBM-induced photodamage of organelles was neutralized by autophagy maintained in these cells. However, photodynamic therapy may effectively exploit this behaviour to generate apoptosis in cancer treatment, which may increase the treatment efficacy and open up prospects for further applications.